Similar articles

• [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].

  Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA. Arbuzova SB, et al. Tsitol Genet. 1998 Jan-Feb;32(1):66-71. Tsitol Genet. 1998. PMID: 9695254 Russian.
• Prevention of Down syndrome: the Jerusalem experience.

  Bach G, Ben-Neriah Z, Sagi M. Bach G, et al. Isr J Med Sci. 1993 Aug;29(8):468-70. Isr J Med Sci. 1993. PMID: 7691779 No abstract available.
• First- and second-trimester screening: detection of aneuploidies other than Down syndrome.

  Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Breathnach FM, et al. Obstet Gynecol. 2007 Sep;110(3):651-7. doi: 10.1097/01.AOG.0000278570.76392.a6. Obstet Gynecol. 2007. PMID: 17766613
• Evaluation of Down syndrome screening strategies.

  Wenstrom KD. Wenstrom KD. Semin Perinatol. 2005 Aug;29(4):219-24. doi: 10.1053/j.semperi.2005.05.014. Semin Perinatol. 2005. PMID: 16104672 Review.
• Down syndrome: prenatal risk assessment and diagnosis.

  Newberger DS. Newberger DS. Am Fam Physician. 2000 Aug 15;62(4):825-32, 837-8. Am Fam Physician. 2000. PMID: 10969860 Review.